SAPK7 (SnRK2 family member) is implicated in:
Phosphorylation events: Critical for plant-virus interactions, such as phosphorylating the Chinese wheat mosaic virus (CWMV) cysteine-rich protein (CRP) at residues S162/S165, facilitating viral evasion of plant immunity .
Stress signaling: SnRK2 kinases typically mediate responses to abiotic stresses (e.g., drought, salinity) .
Although SAPK7-specific antibodies are not explicitly reported, analogous antibody-based techniques could be applied:
Kinase activity: TaSAPK7 phosphorylates CWMV CRP in a dose-dependent manner, with phosphorylation abolished in S162A/S165A mutants .
Functional impact: Phosphorylated CRP suppresses plant immune responses, enhancing viral infectivity .
| Homolog | Sequence Identity | Genomic Location |
|---|---|---|
| TraesCS2A02G303900.1 | 99.91% | Chromosome 2A |
| TraesCS2B02G320500.1 | 99.91% | Chromosome 2B |
| TraesCS2D02G302500.1 | 99.91% | Chromosome 2D |
| Parameter | ELISA | Western Blot | Flow Cytometry |
|---|---|---|---|
| Sensitivity | 1–10 ng/mL | 0.1–1 μg total protein | 10³–10⁴ cells/sample |
| Target | Phosphorylated CRP | SAPK7 (~40–50 kDa) | Intracellular SAPK7 |
| Citation |
SAPK7 phosphorylates CWMV CRP at residues S162/S165, enabling the virus to evade wheat immunity by altering host RNA-binding protein interactions. Methodologically, this is demonstrated through:
Yeast two-hybrid (Y2H) screens to identify SAPK7-CRP interactions (Fig. 3A) .
Bimolecular fluorescence complementation (BiFC) and luciferase (LUC) assays to confirm kinase-substrate binding in planta (Fig. 3B–C) .
In vitro kinase assays using [γ-32P] ATP to quantify phosphorylation (Fig. 3D–F) .
These approaches validate SAPK7 as the primary kinase responsible for CRP modification, with phosphorylation-mimetic mutants (CRP S162/165D) showing enhanced viral pathogenicity.
A validated protocol involves:
Co-immunoprecipitation (Co-IP) using anti-SAPK7 antibodies to isolate kinase complexes from wheat or Nicotiana benthamiana extracts.
Phosphorylation-specific antibodies targeting CRP S162/S165, though these require validation via:
Site-directed mutagenesis (e.g., S→A or S→D substitutions).
Mass spectrometry to confirm phosphorylation sites.
Radiolabeled ATP assays to measure kinase activity (Fig. 3D) .
The unexpected phosphorylation of CRP S162/165D in vitro (Fig. 3F) highlights two hypotheses requiring further testing:
Secondary phosphorylation sites: Mutations at S162/S165 may expose cryptic sites (e.g., T160 or Y167) that become accessible for SAPK7.
Conformational dependency: Phosphorylation at S162/S165 may induce structural changes that facilitate SAPK7 activity at other residues.
Methodological recommendations:
Conduct alanine scanning mutagenesis across the CRP sequence.
Use phosphoproteomics to map all SAPK7-dependent sites under wild-type and mutant conditions.
Key considerations include:
Epitope validation: Compare antibody performance against SAPK7 knockout lines or siRNA-treated plants.
Cross-reactivity testing: Assess binding to homologs (e.g., SAPK6/SAPK8) using recombinant proteins.
Buffer optimization: Include phosphatase inhibitors (e.g., NaF/β-glycerophosphate) to preserve phosphorylation states during extraction.
Phosphorylated CRP (S162/165D) binds TaUBA2C, a wheat RNA-binding protein, and inhibits its defense functions via:
Subcellular redistribution: CRP-TaUBA2C complexes reduce nuclear speckle formation (critical for RNA processing).
Functional impairment: Phosphorylated CRP reduces TaUBA2C’s RNA/DNA-binding activity by 60%, quantified via electrophoretic mobility shift assays (EMSAs) .
Downstream effects: Silencing TaUBA2C increases CWMV replication, while overexpression reduces viral load by 70% .